MJFF surpasses $50M with Brin Wojcicki Challenge

Thursday, February 28, 2013 08:00 AM

The Michael J. Fox Foundation for Parkinson's Research (MJFF) it has completed and surpassed the $50 million Brin Wojcicki Challenge. Longtime foundation supporters Sergey Brin and Anne Wojcicki have matched more than $53 million in capacity-building gifts received by MJFF from January 1, 2011, to December 31, 2012.

Brin, a co-founder of Google, and Wojcicki, a co-founder of 23andMe, have been the foundation's largest donors for several years running and spearheaded the challenge to spur donors at every level to give, renew or increase giving to MJFF. Because of the enthusiasm and generosity of the foundation's community of donors, challenge-eligible giving exceeded the original goal by about $3 million, which Brin and Wojcicki have agreed to match.

"Anne and Sergey's friendship to our foundation and to Parkinson's patients worldwide is awe-inspiring," said Michael J. Fox. "As if a $50 million match weren't tremendous in its own right, they've gone above and beyond their initial commitment to match the $3 million extra ponied up by our incredible supporters. There's no doubt the challenge has made our community stronger and more vibrant in its passionate pursuit of a cure."

Over the course of two years, the challenge brought thousands of new contributors to MJFF. It also helped the foundation reactivate relationships with thousands of supporters who had given prior to 2010, and motivated over 4,000 to stretch their giving in order to double the impact of their generosity.

With the completion of the challenge, Brin’s and Wojcicki’s personal giving to MJFF totals more than $157.5 million since 2004.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs